site sponsored by
Tag Archive | "deal"
Tags: 1962-paper, accessed, all-things, chemical news, current-one, deal, list, pyridine-oximes, some-total, stuff
Ancient Chemistry Comes Back to Life?
Posted on 08 September 2010
Posted in In the PipelineComments (0)
Tags: been-successful, biotech deals, deal, discovery, discovery-pact, find-promising, japan, karen-weck, market, more-ambitious, new-antibiotic, regeneron, taking-the-lion, trius therapeutics, underwriters
Regeneron inks $295M antibody discovery deal with Astellas
Posted on 28 July 2010
Posted in Top NewsComments (0)
Tags: biotech deals, companies, deal, familiar-aspect, highest-volume, likely-the-deal, milestone-deals, performs-well, position, the-position, time
Milestones mitigate risk in biotech deals
Posted on 21 July 2010
Posted in Top NewsComments (0)
Tags: better-educated, charles-river, chief-executive, deal, estimated, from-investors, harry-palmin, newton, nov-002, novelos, officer-james, only-the-world, shareholders
Charles River sweetens WuXi merger with ’synergies’
Posted on 13 July 2010
Posted in Top NewsComments (0)
Tags: biotech, deal, epogen, eugene melnyk, international, michael-pearson, News, past, safety, vital-science
Biovail, Valeant Pharma strike merger deal
Posted on 21 June 2010
Posted in Top NewsComments (0)
Tags: biotech, deal, fully-committed, japan, japanese, kissei pharmaceutical, neuroges, protox, royalty-partners, urological
Protox gets $3M upfront in $75M deal with Kissei
Posted on 30 April 2010
Posted in Top NewsComments (0)
Tags: article, biotech, complexities, deal, disease-as-high, japan, japanese, risk, technology, urological
Study highlights potential benefits of GSK heart drug
Posted on 30 April 2010
Posted in Top NewsComments (0)
Tags: aptuit-laurus, biotech, china, deal, human-genome, indian, laurus-labs, lonza group, monthly-dose, new-enterprises, paving-the-way, third-facility
Buzz: Lonza in talks to buy control of Indian R&D ops
Posted on 24 March 2010
Posted in Top NewsComments (0)
Tags: aptuit-laurus, biotech, deal, drug-picoplatin, francisco-based, lonza group, morning, poniard pharmaceuticals
Struggling Poniard lays off more workers as it ponders options
Posted on 24 March 2010
Posted in Top NewsComments (0)
Tags: basilea, biotech, current, deal, imclone, japanese, partnership, reuters, takeover-target
Basilea lands $510M co-marketing pact with Astellas
Posted on 24 February 2010
Posted in Top NewsComments (0)
Ask Our Experts
Heather R. Powell
Regulatory
Dawn Obermoeller
Social Media
Jonathan Richman
Non-Personal Promotion
Optimize RX
Internet Marketing & Analytics
Share Your Knowledge
We are always seeking seasoned pharmaceutical marketing professonals as contributors. If you have a strong background in pharmacetical marketing, and are interested in sharing your skills and knowledge with our community, or syndicating your existing blog posts, please click here.
- Popular
- Latest
- Comments
- Tags
- Subscribe
- J&J Prostate Cancer Drug Boosts Survival
- Bristol-Myers starts tender offer for ZymoGenetics
- Yet Another Reason That Sanofi-Genzyme Deal Will Go Through
- Savient: Drug Approval or Another Delay?
- MedImmune Bets Its Fate on âBiobettersâ
- Tekmira to delay start of trial for TKM-ApoB
- Weekly Roundup - 09/10/10
- J&J unit’s prostate cancer drug improves survival
- FDA: Don’t believe everything you read on drug studies
- Top 10 reasons you should join us for the Multi Channel Pharma Marketing Event?
- Optimize RX: yep - recvd - thanks - how much daily u.v.'s r u g...
- JMB: This is another bashing article from an author who...
- Martin: It's just silly of you to obsess over the possibil...
- Gregg Feris: Jon, Thanks for the in depth reply. I like the ...
- Doc: Why should Exxon have to pay this fine for somethi...
2009
adpharm
adpharm gallery
advertising
alpha
biotech
bnet
branded
business
development
drug
DTC
english
europe
fda
fierce-biotech
fierce pharma
gallery
hcp
health
industry
internet
largest
marketing
motley-fool
News
north
north america
north_america
online
online-pharmaceutical
pharma
Print
print_ad
Regulatory
sales
seeking-alpha
single-page
Social Media
technology
the-gallery
the-largest
time
usa
wsj
Stay up to date
- Subscribe to the RSS Feed
